Lausanne, Switzerland - March 26, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Pharmigene, a...

We are excited we can announce the availability of GTEx tissue-specific gene expression data and dbNSFP 4.0 Genes.

Lausanne, Switzerland – March 26, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with ILC –...

Lausanne, Switzerland - March 24, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Fuentes Bono...

Lausanne, Switzerland - February 4, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Evolve...

Lausanne, Switzerland - January 16, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Danyel...

Lausanne, Switzerland - January 13, 2020 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Shiva...

We are releasing Mitomap and Variable Strength for ACMG Criteria for the free VarSome.com.

Lausanne, December 3st, 2019. Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions, announced today a partnership with 4bases SA, a Swiss-based company specialized in the development,...

We are proud to present the latest version of VarSome Clinical with the following new features and improvements.

Although NGS technology is increasingly available in clinical settings, the main challenge remains the interpretation of sequencing data, especially when it comes to larger data sets, such as exomes and genomes. The MedSeq Project examined the...

Lausanne, Switzerland - October 3, 2019 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a distribution agreement with Varelas, a...